Intervention

Dulaglutide

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 68 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials68
Recruiting2
Common conditions25
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)NCT06739122 · 2025-01-10
RECRUITING
Therapeutic Strategies for Microvascular Dysfunction in Type 1 DiabetesNCT05478707 · 2023-10-05
RECRUITING
Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes MellitusNCT07677891 · 2026-10-01
NOT_YET_RECRUITING
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesNCT07668336 · 2026-09-01
NOT_YET_RECRUITING
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney DiseaseNCT07537088 · 2026-05-01
NOT_YET_RECRUITING
Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.NCT07417631 · 2026-02-03
COMPLETED
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)NCT07417618 · 2026-01-27
COMPLETED
Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular RiskNCT07619495 · 2026-01-20
COMPLETED
A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes MellitusNCT07313813 · 2025-12-29
COMPLETED
Weekly GLP-1 Receptor Agonists in Obese Individuals Without DiabetesNCT07834398 · 2025-11-14
COMPLETED
Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes MellitusNCT07319286 · 2025-08-04
ENROLLING_BY_INVITATION
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.NCT06851962 · 2025-05-26
COMPLETED
Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesNCT06779929 · 2024-11-01
COMPLETED
Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims DataNCT07088718 · 2024-10-01
COMPLETED
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular RiskNCT07096063 · 2024-10-01
COMPLETED
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With MetforminNCT06257966 · 2024-07-17
ACTIVE_NOT_RECRUITING
A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes MellitusNCT06235086 · 2024-04-08
COMPLETED
A Study of HS-20094 in Patients With T2DMNCT06901648 · 2024-02-06
COMPLETED
Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2DNCT05140694 · 2023-12-01
UNKNOWN
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DMNCT05680129 · 2023-01-10
COMPLETED
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in IndiaNCT05659537 · 2022-12-29
COMPLETED
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)NCT05564039 · 2022-11-30
COMPLETED
A Study of LY3532226 in Participants With Type 2 Diabetes MellitusNCT05407961 · 2022-06-07
COMPLETED
A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 DiabetesNCT05377333 · 2022-06-02
COMPLETED
Basal Plus GLP1-ra on Glycemic Variability in CKDNCT05218915 · 2022-01-28
COMPLETED
A Study of LY3502970 in Participants With Type 2 Diabetes MellitusNCT05048719 · 2021-09-15
COMPLETED
A Study of IBI362 in Chinese Patients With Type 2 DiabetesNCT04965506 · 2021-09-06
COMPLETED
A Study of LY3437943 in Participants With Type 2 DiabetesNCT04867785 · 2021-05-13
COMPLETED
The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.NCT05005741 · 2021-05-01
UNKNOWN
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 DiabetesNCT04809220 · 2021-04-13
COMPLETED
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 DiabetesNCT04591626 · 2020-12-07
COMPLETED
A Study of LY3457263 in Healthy Participants and Participants With Type 2 DiabetesNCT04641312 · 2020-11-25
COMPLETED
Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DMNCT04466904 · 2020-09-12
COMPLETED
A Study of LY3493269 in Participants With Type 2 DiabetesNCT04515576 · 2020-08-25
COMPLETED
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesNCT04255433 · 2020-05-29
COMPLETED
Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 DiabetesNCT04893148 · 2020-05-26
UNKNOWN
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic ResponseNCT04387201 · 2020-05-15
COMPLETED
Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using MetforminNCT04829903 · 2020-01-02
COMPLETED
A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)NCT04143802 · 2019-12-18
COMPLETED
Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide scNCT04189848 · 2019-12-03
COMPLETED
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 DiabetesNCT03861052 · 2019-05-07
COMPLETED
Dulaglutide and Insulin MicrosecretiON in Type 1 DiabetesNCT03668470 · 2019-01-31
COMPLETED
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseNCT03590626 · 2019-01-01
COMPLETED
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With MetforminNCT03684642 · 2018-09-26
TERMINATED
Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)NCT05946148 · 2018-06-01
COMPLETED
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 DiabetesNCT03495102 · 2018-04-05
COMPLETED
The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and AlbuminuriaNCT06611904 · 2018-02-01
UNKNOWN
Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 DiabetesNCT03444142 · 2017-11-17
UNKNOWN
A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 DiabetesNCT03315780 · 2017-10-28
COMPLETED
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes MellitusNCT03131687 · 2017-05-24
COMPLETED
Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory VariablesNCT03824002 · 2017-04-01
COMPLETED
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 DiabetesNCT03015220 · 2017-01-10
COMPLETED
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 DiabetesNCT02963766 · 2016-12-29
COMPLETED
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin MonotherapyNCT02973100 · 2016-12-01
COMPLETED
A Study of Dulaglutide in Japanese Participants With Type 2 DiabetesNCT02750410 · 2016-08-01
COMPLETED
A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)NCT02759107 · 2016-05-11
COMPLETED
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.NCT02648204 · 2016-01-06
COMPLETED
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusNCT02597049 · 2015-11-01
COMPLETED
A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesNCT02152371 · 2014-05-01
COMPLETED
Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)NCT01769378 · 2013-01-01
COMPLETED

Common conditions

Leading sponsors

Trial status mix

COMPLETED55
UNKNOWN5
NOT_YET_RECRUITING3
RECRUITING2
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1
TERMINATED1

Phase mix

PHASE322
PHASE414
PHASE113
PHASE211
NA3
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.